Please assess the completion status of the following clinical trial:

Trial Title: Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Subjects aged 40 and over who are scheduled to undergo colonoscopy at the research site and who are classified in category P2, P3 or P4.~2. Subjects who provide informed consent to participate in the trial~Exclusion Criteria:~1. Lack of understanding and/or participation due to illiteracy or inability to comprehend English or French~2. Subjects in category P3 who are there due to knowledge or suspicion of an inflammatory bowel disease~3. Previous history of cancer (any type) or active infection (as declared by the subject at the time of enrolment)~4. Currently participating (or participated within the previous 120 days) in an investigational therapeutic study (in case of interference of the drug with the immune system)~5. Subjects who underwent their colonoscopy and~   1. the colonoscopy preparation was judged insufficient~  2. the colonoscopy itself was judged insufficient or incomplete by the doctor~  3. the biopsy sample was lost and cancer could not be pathologically confirmed~  4. the colonoscopy detected an inflammatory bowel disease~6. Female who is pregnant, nursing, or of child-bearing potential while not practicing effective contraceptive methods.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).